1 completed, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis Group A- Tofacitinib, Group B- Methotrexate - Psoriatic Arthritis | Phase 3 | Completed | Globe Pharmaceuticals Limited | 61 | 2017-09-15 | 2019-10-21 |
| Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial Tofacitinib - Axial Spondyloarthritis | Phase 2 / Phase 3 | Unknown | Globe Pharmaceuticals Limited | 30 | 2017-09-01 | 2018-11-13 |
Arthritis, Psoriatic (1) · Axial Spondyloarthritis (1)
tofacitinib (2) · Methotrexate (1)
Bangladesh (2)
Asadul Islam, MBBS (1) · Prayush Sharma, MD (1)
PMID 15528283, PMID 18503600, PMID 18975321, PMID 19060002, PMID 21994233, PMID 22344575, PMID 25593233, PMID 26357944, PMID 26669913, PMID 28130206, PMID 29045207, PMID 29045212, PMID 29399784, PMID 29435359, PMID 3659255